CStone Pharmaceuticals

📍 Shanghai, China🗓 Founded 2016👥 240 employees💰 Last funded Oct 2015
Pharmaceutical Manufacturing🌐 cstonepharma.com
Website LinkedIn
CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, CStone has received nine NDA approvals for four drugs. Multiple late-stage drug candidates are now under pivotal clinical trials or registration. CStone's vision is to become globally recognized as a world-renowned biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CStone Pharmaceuticals?
CStone Pharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CStone Pharmaceuticals last raise funding?
The most recent investment in CStone Pharmaceuticals recorded on gritt.io was in October 2015.
When was CStone Pharmaceuticals founded?
CStone Pharmaceuticals was founded in 2016.
What industry is CStone Pharmaceuticals in?
CStone Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is CStone Pharmaceuticals based?
CStone Pharmaceuticals is headquartered in Shanghai, China.